| Followers | 245 |
| Posts | 13889 |
| Boards Moderated | 0 |
| Alias Born | 05/19/2015 |
Monday, April 15, 2019 2:36:30 PM
LONG's don't get tired they get UP just like money in the bank. Shorts will HOP right back down the Rabbit hole as the tide turns again!
Allume deal means shorts will be eating Crow! O/S shares only 33 million. ONCE Brazils 5th largest and 40 year old company LOI becomes a contract with GCAN and GCAN only has 33 million O/S With all these new deals and GCAN becoming discovered. GCAN could very well see many more 100% days.
If we look at GCAN's trading history the biggest volume day so is today and the next was a little over 10 million shares and every time GCAN gets up over a couple of million or better in volume in one day it has moved over 100% in hours even with MM's naked shorting half or better of that volume:
Sep 19 2018
change +166.49% up
Volume 2,588,518
Oct 03 2018
change +231.25% up
Volume 4,913,665
Nov 02 2018
change +111.46% up
Volume 10,574,248
https://www.gcanrx.com/our-technology.html
What makes GCAN dollars realistic compared to other cannabis stocks is it's extremely low 33 million O/S and GCAN's super Low Float along with a great Team, Quality Leadership and Name brand. Who knows how high GCAN will go. Just compare GCAN with It's extremely low 33 million O/S and super Low Float to other cannabis stocks like Aurora that have nearly 1 billion O/S. GCAN is still undiscovered by the Masses like Aurora was a few years ago when it was trading in the pennies also.
Look and Compare:
GCAN: Outstanding Shares 33 million O/S Trading in the pennies
Aurora: Outstanding Shares 958 million O/S Trading at $9.00
Allume Cosmeticos is the Real Deal and so is GCAN that will provide ALLUME the formulations to infuse pharmaceutical-grade CBD, into a new line of cosmetics, …
https://thedailyrecord.com/2019/04/12/maryland-greater-cannabis-allume-cosmeticos/
GCAN's other agreement is with iCAN and will include commercial ready formulations to meet medical and recreational market demands. Distribution and marketing rights for iCAN will include Israel, Australia, South Africa, Netherlands, South Africa, Mexico, Colombia, Panama, Germany, Austria, Switzerland, Malta, Macedonia, and Portuguese territories.
Allume deal means shorts will be eating Crow! O/S shares only 33 million. ONCE Brazils 5th largest and 40 year old company LOI becomes a contract with GCAN and GCAN only has 33 million O/S With all these new deals and GCAN becoming discovered. GCAN could very well see many more 100% days.
If we look at GCAN's trading history the biggest volume day so is today and the next was a little over 10 million shares and every time GCAN gets up over a couple of million or better in volume in one day it has moved over 100% in hours even with MM's naked shorting half or better of that volume:
Sep 19 2018
change +166.49% up
Volume 2,588,518
Oct 03 2018
change +231.25% up
Volume 4,913,665
Nov 02 2018
change +111.46% up
Volume 10,574,248
https://www.gcanrx.com/our-technology.html
What makes GCAN dollars realistic compared to other cannabis stocks is it's extremely low 33 million O/S and GCAN's super Low Float along with a great Team, Quality Leadership and Name brand. Who knows how high GCAN will go. Just compare GCAN with It's extremely low 33 million O/S and super Low Float to other cannabis stocks like Aurora that have nearly 1 billion O/S. GCAN is still undiscovered by the Masses like Aurora was a few years ago when it was trading in the pennies also.
Look and Compare:
GCAN: Outstanding Shares 33 million O/S Trading in the pennies
Aurora: Outstanding Shares 958 million O/S Trading at $9.00
Allume Cosmeticos is the Real Deal and so is GCAN that will provide ALLUME the formulations to infuse pharmaceutical-grade CBD, into a new line of cosmetics, …
https://thedailyrecord.com/2019/04/12/maryland-greater-cannabis-allume-cosmeticos/
GCAN's other agreement is with iCAN and will include commercial ready formulations to meet medical and recreational market demands. Distribution and marketing rights for iCAN will include Israel, Australia, South Africa, Netherlands, South Africa, Mexico, Colombia, Panama, Germany, Austria, Switzerland, Malta, Macedonia, and Portuguese territories.
Recent GCAN News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 08:22:05 PM
- GCANRx Announces Relisting To OTCQB Market Tier • GlobeNewswire Inc. • 12/03/2025 12:45:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 10/16/2025 03:13:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/15/2025 11:00:32 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2025 02:05:11 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 08/08/2025 01:56:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/12/2025 03:57:40 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 05/06/2025 12:54:51 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 05/05/2025 10:09:45 AM
